Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
04:05pm, Thursday, 20'th Apr 2023
CAMBRIDGE, MA / ACCESSWIRE / April 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live c
Where Will Moderna Be in 1 Year?
09:24am, Thursday, 20'th Apr 2023
Moderna's coronavirus vaccine business will lose steam in the next 12 months. The company is looking at steady progress with its pipeline.
Is Moderna About to Face the Same Challenge as Other Biotechs?
06:00am, Thursday, 20'th Apr 2023
Moderna reported positive data from its personalized cancer vaccine candidate. The biotech company aims to expand beyond its blockbuster coronavirus vaccine program.
Moderna Stock: Bear vs. Bull
02:00pm, Wednesday, 19'th Apr 2023
Moderna's coronavirus vaccine sales are on the decline -- and that has investors worrying about the future. Still, Moderna may not be a one-product company for very long.
FDA Gives Nod for Using Bivalent Jab for All COVID Vaccinations
09:55am, Wednesday, 19'th Apr 2023
To simplify the COVID-19 vaccination schedule for all individuals, the FDA authorizes using bivalent COVID-19 vaccines for all doses administered to individuals aged six years and older.
MRNA Stock Drops But Options Are Cheap; Play The Downside With This Debit Spread | IBD
03:27pm, Tuesday, 18'th Apr 2023
Using a bear put spread, here's how you can bet on a move to the downside in Covid vaccine maker Moderna while limiting your risk. New to trading?
Top Stocks To Buy Now? 3 Healthcare Stocks To Know
12:04pm, Tuesday, 18'th Apr 2023
Healthcare stocks for your Mid-April 2023 watchlist.
FDA authorizes additional omicron Covid shots for seniors and people with weak immune systems
11:52am, Tuesday, 18'th Apr 2023
Although the burden of the pandemic has eased substantially, the CDC says Covid continues to kill more than 1,300 people per week.
Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?
05:50am, Tuesday, 18'th Apr 2023
Moderna's experimental flu vaccine works well against influenza A strains but not against B strains (so far). This further solidifies Novavax's lead in the race to develop a combination COVID-19/flu v
These 2 Stocks Were Monday's Big Disappointments
06:46pm, Monday, 17'th Apr 2023
Stock markets overcame weakness earlier in the day on Monday to finish modestly higher. Roblox reported business metrics for the month of March that raised concerns among shareholders about future gro
Why Moderna Stock Plunged Today
04:16pm, Monday, 17'th Apr 2023
Moderna disclosed positive results from a cancer trial over the weekend. However, results weren't better than already high expectations.
Moderna Slumps as Vaccine Momentum Wanes
12:59pm, Monday, 17'th Apr 2023
Moderna ( MRNA , Financial) emerged as one of the biggest beneficiaries of the pandemic after it developed one of the first Covid-19 vaccines. However, the momentum created by the pandemic is fading,
Moderna (MRNA), Merck's Cancer Jab Delays Melanoma Recurrence
12:56pm, Monday, 17'th Apr 2023
Detailed data from a mid-stage study shows that Moderna (MRNA)/Merck's personalized cancer vaccine candidate reduces the risk of recurrence/death.
Moderna Cancer-Therapy Sees More Upbeat Data
11:32am, Monday, 17'th Apr 2023
New data bolster the case for Moderna's experimental cancer treatment, but the path to turning it into a marketable product remains a long one.
Moderna shares fall despite promising data from cancer vaccine trial
11:30am, Monday, 17'th Apr 2023
Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.
